Evidence map›Paper›PMID 30375703›Full record

ArticleBipolar disorders2019

Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: An ISBD task force report.

Kenneth I Shulman, Osvaldo P Almeida, Nathan Herrmann, Ayal Schaffer, Sergio A Strejilevich, Christina Paternoster, Sean Amodeo, Annemiek Dols, Martha Sajatovic

Open access · hybridAbstract read
In one paragraph

Article in Bipolar disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Low-dose lithium, neuroprotection, and brain aging in bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The spectrum of bipolar disorder in older adults.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Lithium: current state of the art and future directions.International journal of bipolar disorders · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Kenneth I ShulmanDepartment of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-6558-5770
Osvaldo P AlmeidaWestern Australian Centre for Health & Ageing, Medical School, University of Western Australia, Perth, Australia.ORCID 0000-0002-8689-6199
Nathan HerrmannDepartment of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Ayal SchafferDepartment of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-6220-5042
Sergio A StrejilevichBipolar Disorder Program, Neurosciences Institute, Favaloro University, Buenos Aires, Argentina.ORCID 0000-0001-8410-7187
Christina PaternosterInternational Society for Bipolar Disorders, Pittsburgh, Pennsylvania.
Sean AmodeoDepartment of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Annemiek DolsDepartment of Old Age Psychiatry, GGZinGeest/Vumc, Amsterdam, the Netherlands.ORCID 0000-0003-1964-0318
Martha SajatovicDepartment of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio.
Sunnybrook Health Science Centre · CAFavaloro University · ARGGZ inGeest · NLOncology Nursing Society · USThe University of Western Australia · AUUniversity Hospitals of Cleveland · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDespite the growing numbers and proportion of older adults with bipolar disorder (OABD), there are very limited guidelines for the use of lithium with its double-edged potential for effectiveness and toxicity in this population. The primary aims of this Delphi survey were: (a) To determine the place of lithium among the preferred choices for maintenance treatment of OABD. (b) To provide detailed clinical guidelines for the safe and effective use of lithium in OABD.

methodsIn the face of limited evidence, the Delphi survey method was used to achieve consensus by a group of 25 experts in OABD from nine countries. An oversight committee monitored and analyzed the results of each survey and formulated more focused questions with each subsequent iteration.

resultsA 100% response rate was achieved for all three iterations of the survey. Lithium was the preferred choice for maintenance monotherapy in OABD. Serum levels of 0.4-0.8 mmol/L were recommended for ages 60-79 and serum levels of 0.4-0.7 mmol/L were recommended for ages 80 and over. Specific recommendations achieved consensus for second line monotherapy as well as for other drugs to be used in combination with lithium if necessary. Guidelines for routine monitoring of lithium in OABD were provided for laboratory investigations and clinical assessments.

conclusionsLithium remains the preferred choice for maintenance monotherapy in OABD. Laboratories should report the therapeutic range for serum levels of lithium separately for older adults.

Indexed as

Advisory CommitteesAgedAged, 80 and overAge FactorsBipolar DisorderDelphi TechniqueHumansLithium CompoundsMiddle AgedPractice Guidelines as TopicSurveys and QuestionnairesLithium CompoundsDelphilithiummaintenanceolder adults

Identifiers

PMID30375703
PMCPMC6587471
OpenAlexW2898775361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.